# The Atypical Presentation of Diffuse Large B-cell Lymphoma in a Lower Limb Soft Tissue Mass: A Case Report

**Authors:** Filipe Leal, Amélia Gaspar, Cristina Silva, Clarisse Coelho, Ana Sofia Martins

PMC · DOI: 10.7759/cureus.86676 · Cureus · 2025-06-24

## TL;DR

An 80-year-old man's leg mass was initially mistaken for an infection, but it was later diagnosed as a rare form of lymphoma, highlighting the need for early suspicion of cancer in unusual cases.

## Contribution

This case highlights the diagnostic challenges of extranodal DLBCL presenting as a soft tissue mass mimicking infection.

## Key findings

- The patient's mass was misdiagnosed as cellulitis before being identified as DLBCL.
- Delayed diagnosis and limited imaging access contributed to poor outcomes.
- Extranodal DLBCL can present atypically, requiring high clinical suspicion for accurate diagnosis.

## Abstract

We report a case of an 80-year-old male with a progressively enlarging, painful mass in the left lower limb, initially misdiagnosed as cellulitis. The patient did not respond to antibiotic therapy, prompting further investigation. Imaging revealed two large soft tissue masses, and biopsy confirmed diffuse large B-cell lymphoma (DLBCL) of germinal center origin. Despite treatment with R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy and palliative radiotherapy, the disease progressed, and the patient died approximately one year after diagnosis. This report illustrates the diagnostic challenge posed by extranodal DLBCL when it mimics common soft tissue infections. Delayed diagnosis in our case was caused by the benign clinical presentation and limited access to imaging in the primary care setting. Clinicians should maintain a high index of suspicion for malignancy in atypical or unresponsive soft tissue lesions. Early referral, multidisciplinary evaluation, and appropriate imaging are critical to improving outcomes in such rare presentations.

## Linked entities

- **Chemicals:** cyclophosphamide (PubChem CID 2907), doxorubicin (PubChem CID 31703), vincristine (PubChem CID 5978), prednisone (PubChem CID 5865)
- **Diseases:** cellulitis (MONDO:0005230), diffuse large B-cell lymphoma (MONDO:0018905), DLBCL (MONDO:0018905)

## Full-text entities

- **Diseases:** Soft (MESH:C562950), soft tissue lesions (MESH:D012983), infections (MESH:D007239), cellulitis (MESH:D002481), DLBCL (MESH:D016403), malignancy (MESH:D009369)
- **Chemicals:** R-CHOP (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12289106/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12289106/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12289106/full.md

---
Source: https://tomesphere.com/paper/PMC12289106